PharmaVoice

MAY 2, 2025

Regulators have signaled their willingness to embrace alternative tests and guide the industry in new directions.

194

194

Fierce Healthcare

MAY 2, 2025

Policymakers must stop pretending the healthcare system will hold without vital funding and stronger support for emergency physicians, American College of Emergency Physicians President Alison Haddock, M.D., writes.

101

101

pharmaphorum

MAY 2, 2025

Shares in Eli Lilly have weakened after pharmacy benefit manager CVS Health said it would no longer cover its weight-loss therapy Zepbound.

100

100

Fierce Healthcare

MAY 2, 2025

A collaboration between Express Scripts and Prime Therapeutics from late 2019 is under the legal microscope again, this time by the Michigan Attorney General. The state says the partnership amounted to collusion and led to pharmacy deserts across the state.

88

88

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharma Tutor

MAY 2, 2025

List of Drug patent expiration 2025 admin Fri, 05/02/2025 - 14:05 Drug patent expiration presents a significant opportunity for the launch of generic medications, which can dramatically alter market dynamics. When a branded drug's patent expires, it opens the door for generic manufacturers to produce and sell bioequivalent versions at a lower cost, leading to increased competition and reduced prices.

Pharmaceutical Companies 94

Pharmaceutical Companies Pharmaceutical Companies 94

pharmaphorum

MAY 2, 2025

A new policy from the NIH in the US will cut billions of dollars of funding for research organisations and hospitals outside the US.

Hospitals 66

Hospitals 66

pharmaphorum

MAY 2, 2025

A planning application has been filed to invest 1bn in "the world's leading centre for cancer research and treatment" in London.

64

64

Fierce Healthcare

MAY 2, 2025

Limbic's Intake Agent responds to patients in real-time and can field an unlimited number of calls, freeing up the workload on overburdened call center staff. It aims to help streamline patient intake.

60

60

Pharmaceutical Technology

MAY 2, 2025

The post-traumatic stress disorder (PTSD) market is expected to grow at a high compound annual growth rate of 16.1% from $1.2bn in 2024 to $5.5bn by 2034 across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Australia), according to leading data and analytics company GlobalDatas recent report, Post-Traumatic Stress Disorder: Opportunity Assessment and Forecast.

Compounding 69

Compounding 69

Fierce Healthcare

MAY 2, 2025

Cigna is doubling down on its efforts to manage the challenges associated with GLP-1s through the launch of two new programs.

72

72

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

MAY 2, 2025

As scientists explore treating genetic disorders before birth, the promise of foetal gene therapy is growingbut there are hurdles to overcome.

52

52

pharmaphorum

MAY 2, 2025

More than a year after it was rejected by the FDA, Satsuma Pharma's intranasal migraine therapy Atzumi has been given the go-ahead by the agency

FDA 59

FDA 59

Pharmaceutical Technology

MAY 2, 2025

The UK MHRA has granted marketing authorisation to Bavarian Nordic's Vimkunya vaccine for preventing the chikungunya virus.

Vaccines 52

Vaccines 52

Pharma Marketing Network

MAY 2, 2025

Trust is no longer a luxury in healthcare marketingits a necessity. In an era where misinformation spreads faster than facts, crafting a healthcare brand strategy that inspires confidence is more essential than ever. As consumers, providers, and payers grow increasingly skeptical of institutional messaging, brands must work harder to earn loyalty. But how do you build trust in a digital ecosystem thats constantly shifting?

Communication 52

Communication Customer Service Pharmaceutical Companies Pharmaceutical Companies 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmaceutical Technology

MAY 2, 2025

Pliant is slashing 45% of its workforce in a move to minimise costs and preserve cash reserves.

52

52

Fierce Healthcare

MAY 2, 2025

UnitedHealth Group and Amedisys have found buyers for key divestitures aimed at getting their $3.3 billion merger over the finish line, according to new filings.

53

53

Pharmaceutical Technology

MAY 2, 2025

4D Molecular Therapeutics (4DMT) has received the regenerative medicine advanced therapy (RMAT) designation from the FDA for 4D-150.

FDA 52

FDA 52

Fierce Healthcare

MAY 2, 2025

EHR giant Epic continued to amass a greater share of the U.S. hospital market in 2024, adding 176 multispecialty hospitals and 29,399 beds. The health IT company now commands 42.3% of the acute care EHR market, up from 39.1% a year prior.

Hospitals 53

Hospitals 53

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

European Pharmaceutical Review

MAY 2, 2025

The US Food and Drug Administration (FDA) has approved Zevaskyn (prademagene zamikeracel) as the first autologous cell-based gene therapy for treating recessive dystrophic epidermolysis bullosa (RDEB) wounds. Also known as pz-cel, the cell sheet-based treatment is applied via a single surgical application. The gene therapy uses a patients keratinocyte cells that have been genetically modified, so that they produce functional Type VII collagen, Abeona Therapeutics explained.

FDA 52

FDA 52

Pharma Marketing Network

MAY 2, 2025

In a digital age overflowing with content, how does a pharma brand truly connect with its audience? Imagine your brand not just being seen, but heardconsistently, authentically, and on demand. Thats the promise of healthcare podcasts , which are rapidly emerging as one of the most powerful tools in pharma marketing. Audio storytelling allows brands to break through the noise without being intrusive.

Communication 52

Communication FDA 52

Pharmaceutical Technology

MAY 2, 2025

The US HHS has launched a $500m initiative to accelerate the development of universal vaccines targeting viruses with pandemic potential.

Vaccines 52

Vaccines 52

Pharmaceutical Commerce

MAY 2, 2025

A multi-national study reveals over half of older adults in several European countries are prescribed five or more medicationsspotlighting the urgent need for better data-driven prescribing strategies.

52

52

Pharmaceutical Technology

MAY 2, 2025

Repare Therapeutics has entered into an out-licensing agreement with Canadian biotechnology firm DCx for discovery platforms and IP.

52

52

pharmaphorum

MAY 2, 2025

Prostate cancer: HCPs discuss emerging treatments, artificial intelligence, and precision medicine on social media Nicole.

52

52

Fierce Healthcare

MAY 2, 2025

Karen DeSalvo, M.D., whose career has spanned medicine, public health and leadership roles in healthcare policy and health tech, plans to retire this summer.

53

53

pharmaphorum

MAY 2, 2025

AstraZeneca's three-drug inhaler Breztri has shown efficacy for uncontrolled asthma in a pair of trials that could extend its label beyond COPD

Labelling 45

Labelling 45

PharmExec

MAY 2, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Drug Topics

MAY 2, 2025

The nations largest PBM is placing Novo Nordisks premier weight-loss drug atop its formulary beginning July 1, 2025.

465

465

STAT

MAY 2, 2025

Theirs is an unusual scientific collaboration, to say the least. Jacob Glanville is an immunologist, who worked for the pharma giant Pfizer before striking out to found startups focused on developing therapies that protect against things like coronaviruses, malaria, HIV, and, more recently, snakebites. Tim Friede is a truck mechanic and snake enthusiast from Wisconsin.

144

144

Drug Topics

MAY 2, 2025

Antonio Ciaccia, President of 3 Axis Advisors, CEO of 46brooklyn Research, and pharmacy benefits expert, discusses the commonly circulated misconceptions about PBMs.

281

281

Pharmacy Times

MAY 2, 2025

A survey showed that 92% of Americans are open to treatments that would slow disease progression.

114

114

Drug Topics

MAY 2, 2025

As pharmacy schools continue to deal with recruitment challenges, the pharmacy workforce has its own set of challenges, including interest in nontraditional roles.

247

247

The Checkup by Singlecare

MAY 2, 2025

Roughly 120 million people in the United States have high blood pressure, a good portion of whom may be taking propranolol (commonly known by the brand names Inderal LA, Inderal XL, and InnoPran XL) to combat it. Propranolol is a beta blocker medication. It treats high blood pressure, irregular heartbeats [ arrhythmia, caused by conditions like atrial fibrillation ], anxiety, migraines, and more, says internist Supriya Rao, MD.

Mayo Clinic 97

Mayo Clinic Dosage 97